Author

Ming Gao

Bristol-Myers Squibb (United States)ORCID 0000-0002-3059-7560Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ming Gao1 paper · China Agricultural University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

Alexander V. RatushnyiD· 1 shared Anil Cengiz· 1 shared N. Ezgi WoodiD· 1 shared Ronny StraubeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alexander V. RatushnyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintJan 31, 2025

Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target expression

N. Ezgi Wood, Anil Cengiz, Ming Gao…·Ronny Straube

This paper uses mathematical models to compare cancer-targeting and stroma-targeting ADCs, finding that stroma-targeting may be more effective in cases of heterogeneous antigen expression.

DOI 10.1101/2025.01.31.635847

mechanistic / dynamical modeldrug response / drug discovery

𝕏 PostBluesky